Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
33.69
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine
August 02, 2021
GlaxoSmithKline Plc (NYSE: GSK) has submitted a marketing application to the FDA seeking approval for PRIORIX for use in active immunization against infection by...
Via
Benzinga
Exposures
Product Safety
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola
August 02, 2021
BioHarvest Sciences Appoints Two Law Firms To Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products ...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More
August 01, 2021
This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge. Other featured articles discuss how to find rising dividends, why some...
Via
Benzinga
GlaxoSmithKline's Scores FDA Approval For First IL-5 Inhibitor In Nasal Polyps
July 30, 2021
The FDA approved GlaxoSmithKline Plc's (NYSE: GSK) Nucala (mepolizumab) for chronic rhinosinusitis with nasal polyps, making it the first IL-5 inhibitor to...
Via
Benzinga
Exposures
Product Safety
News Overload
July 29, 2021
Today US markets managed a rally despite misses in both the growth and employment data.
Via
Talk Markets
GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps
July 29, 2021
From
GlaxoSmithKline plc
Via
Business Wire
Avoid These 7 Stocks in Retirement Like the Plague
July 29, 2021
By, Bob Ciura Investors who are in retirement, or nearing retirement will have different needs than their younger counterparts still in the accumulation phase of their life....
Via
Benzinga
Topics
Retirement
Exposures
Pension
Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients
July 29, 2021
Alector Inc (NASDAQ: ALEC) detailed early data from its lead drug, AL001, INFRONT-2 Phase trial at the Alzheimer's Association International Conference (AAIC...
Via
Benzinga
3 Best Dividend Stocks To Buy With Yields Of More Than 5%
July 29, 2021
Dividend paying companies with stable fundamentals are prominent bets now considering the market’s high volatility. Established stocks AT&T Inc., Vale S.A, and GlaxoSmithKline, each currently yield...
Via
Talk Markets
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript
July 28, 2021
GSK earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Vaccine Demand Boosts GlaxoSmithKline's Q2 Sales, Earnings; Maintains FY21 Guidance
July 28, 2021
GlaxoSmithKline Plc's (NYSE: GSK) turnover was £8.1 billion in Q2, up 6% Y/Y (actual exchange rate AER), 15% (constant exchange rate CER). Pharmaceuticals...
Via
Benzinga
European Commission To Procure 220K Doses Of Glaxo-Vir Biotech's COVID-19 Antibody
July 28, 2021
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of...
Via
Benzinga
Exposures
COVID-19
Banned Merger
July 27, 2021
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood.
Via
Talk Markets
Understanding GlaxoSmithKline's Unusual Options Activity
July 27, 2021
On Tuesday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved up to $39.48. Sentiment: BULLISH Option Type: SWEEP...
Via
Benzinga
Unusual Options Activity Insight: GlaxoSmithKline
July 26, 2021
On Monday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved down to $39.13. Sentiment: BEARISH Option Type: SWEEP...
Via
Benzinga
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
Analyzing GlaxoSmithKline's Unusual Options Activity
July 21, 2021
On Wednesday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved up to $39.33. Sentiment: BEARISH Option Type:...
Via
Benzinga
Don't Buy These 16 Investments In Retirement
July 21, 2021
Nearing retirement, or retired? Here are 16 investments to steer clear of.
Via
Talk Markets
Topics
Retirement
Exposures
Pension
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
July 20, 2021
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (...
Via
Benzinga
Exposures
COVID-19
Weak Week
July 16, 2021
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.
Via
Talk Markets
GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies
July 16, 2021
GlaxoSmithKline Plc (NYSE: GSK) said its anemia drug for patients with chronic kidney disease succeeded in five late-stage trials. The drug, daprodustat, an oral...
Via
Benzinga
GSK To Sell One-Third Of Its UK R&D Site For £400M
July 16, 2021
GlaxoSmithKline plc (NYSE: GSK) is planning to sell more than one-third of its 92-acre R&D site in Stevenage, the U.K. The Company is looking to sell 33...
Via
Benzinga
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
July 15, 2021
Moderna Inc (NASDAQ: MRNA) stock is on a roll, with its vaccine-induced momentum spilling over into 2021. The Massachusetts-based company, which had a modest beginning...
Via
Benzinga
Exposures
COVID-19
Dialing For Stocks
July 14, 2021
Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
5 French Stocks To Consider For Bastille Day
July 14, 2021
Bastille Day is France’s National Day, celebrating the Storming of the Bastille on July 14, 1789, a key turning point in the French Revolution. And while the French concept...
Via
Benzinga
Yellow Card
July 12, 2021
The price of oil fell about 1% today.
Via
Talk Markets
The Past Week's Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More
July 11, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Initial and secondary public offerings enticed insiders to...
Via
Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
A Look Into GlaxoSmithKline's Price Over Earnings
July 08, 2021
Looking into the current session, GlaxoSmithKline Inc. (NYSE:GSK) is trading at $39.92, after a 0.80% drop. Over the past month, the stock decreased by 0.78%, but over the...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.